Phylox®, a Natural Solution for Coccidiosis, Now Available in the Philippines
Amlan International, a subsidiary of Oil-Dri of America (NYSE: ODC), has launched Phylox®, a natural anticoccidial solution for poultry, in the Philippines. This innovative feed additive addresses the significant challenge of coccidiosis in Southeast Asian poultry farms, particularly during the rainy season. Phylox offers a safe, effective alternative to traditional chemical drugs and antibiotics, aligning with the growing demand for no-antibiotic-ever (NAE) production systems.
The product will be distributed by Nezus Philippines and showcased at ILDEX 2024 from August 28-30. Phylox has demonstrated performance equivalent to common ionophores or chemicals in trials and is compatible with anticoccidial vaccines. Its multiple modes of action in disrupting Eimeria life cycles position it as a promising solution for enhancing poultry health and profitability in the Asia Pacific market.
Amlan International, una filiale di Oil-Dri of America (NYSE: ODC), ha lanciato Phylox®, una soluzione anticoccidiale naturale per il pollame, nelle Filippine. Questo innovativo additivo per mangimi affronta la significativa sfida della coccidiosi nelle fattorie avicole del sud-est asiatico, in particolare durante la stagione delle piogge. Phylox offre un'alternativa sicura ed efficace ai tradizionali farmaci chimici e agli antibiotici, in linea con la crescente domanda di sistemi di produzione senza antibiotici (NAE).
Il prodotto sarà distribuito da Nezus Philippines e sarà presentato all'ILDEX 2024 dal 28 al 30 agosto. Phylox ha dimostrato prestazioni equivalenti ai comuni ionofori o prodotti chimici nei trial ed è compatibile con i vaccini anticoccidiali. I suoi molteplici meccanismi d'azione nel disturbare i cicli vitali di Eimeria lo posizionano come una soluzione promettente per migliorare la salute e la redditività del pollame nel mercato dell'Asia Pacifico.
Amlan International, una subsidiaria de Oil-Dri of America (NYSE: ODC), ha lanzado Phylox®, una solución anticoccidial natural para aves de corral, en Filipinas. Este innovador aditivo alimentario aborda el importante desafío de la coccidiosis en granjas avícolas del sudeste asiático, especialmente durante la temporada de lluvias. Phylox ofrece una alternativa segura y efectiva a los medicamentos químicos y antibióticos tradicionales, alineándose con la creciente demanda de sistemas de producción sin antibióticos (NAE).
El producto será distribuido por Nezus Philippines y se presentará en ILDEX 2024 del 28 al 30 de agosto. Phylox ha demostrado un rendimiento equivalente a los ionóforos comunes o productos químicos en ensayos y es compatible con las vacunas anticoccidiales. Sus múltiples modos de acción en la interrupción de los ciclos vitales de Eimeria lo posicionan como una solución prometedora para mejorar la salud y la rentabilidad del ave de corral en el mercado de Asia-Pacífico.
Amlan International는 Oil-Dri of America (NYSE: ODC)의 자회사로, 필리핀에서 가축을 위한 자연적인 항코크시디아 솔루션인 Phylox®를 출시했습니다. 이 혁신적인 사료 첨가제는 남동아시아 가금류 농장에서 특히 우기 동안 코크시디오시스의 중요한 문제를 해결합니다. Phylox는 전통적인 화학 약물 및 항생제에 대한 안전하고 효과적인 대안을 제공하며, 항생제 없는 생산 시스템 (NAE)에 대한 증가하는 요구와 일치합니다.
이 제품은 Nezus Philippines를 통해 배급되며 8월 28일부터 30일까지 ILDEX 2024에서 전시될 예정입니다. Phylox는 시험에서 일반 이온포르 또는 화학물질과 동등한 성능을 보였으며, 항코크시디아 백신과 호환됩니다. Eimeria 생명 주기를 방해하는 여러 작용 방식으로 인해 아시아 태평양 시장에서 가금류 건강 및 수익성을 개선하기 위한 유망한 솔루션으로 자리 잡고 있습니다.
Amlan International, une filiale de Oil-Dri of America (NYSE: ODC), a lancé Phylox®, une solution anticoccidienne naturelle pour le volaille, aux Philippines. Cet additif alimentaire innovant répond au défi majeur de la coccidiose dans les fermes avicoles d'Asie du Sud-Est, notamment pendant la saison des pluies. Phylox offre une alternative sûre et efficace aux médicaments chimiques et aux antibiotiques traditionnels, en accord avec la demande croissante pour des systèmes de production sans antibiotiques (NAE).
Le produit sera distribué par Nezus Philippines et présenté lors de ILDEX 2024 du 28 au 30 août. Phylox a démontré des performances équivalentes à celles des ionophores ou des produits chimiques courants lors d'essais et est compatible avec les vaccins anticoccidiens. Ses multiples modes d'action perturbant les cycles de vie d'Eimeria le positionnent comme une solution prometteuse pour améliorer la santé et la rentabilité des volailles sur le marché Asie-Pacifique.
Amlan International, eine Tochtergesellschaft von Oil-Dri of America (NYSE: ODC), hat Phylox®, eine natürliche Anticoccidial-Lösung für Geflügel, auf den Philippinen eingeführt. Dieses innovative Futtermittel-Additiv greift die bedeutende Herausforderung der Kokzidiose in den Geflügelfarmen Südostasiens an, insbesondere während der Regenzeit. Phylox bietet eine sichere, effektive Alternative zu traditionellen chemischen Arzneimitteln und Antibiotika und entspricht der wachsenden Nachfrage nach antibiotikafreien Produktionssystemen (NAE).
Das Produkt wird von Nezus Philippines vertrieben und auf der ILDEX 2024 vom 28. bis 30. August präsentiert. Phylox hat in Tests eine Leistung gezeigt, die mit gängigen Ionophoren oder Chemikalien vergleichbar ist, und ist mit anticoccidialen Impfstoffen verträglich. Seine vielfältigen Wirkungsweisen zur Störung der Lebenszyklen von Eimeria positionieren es als vielversprechende Lösung zur Verbesserung der Gesundheit und Rentabilität von Geflügel im Asien-Pazifik-Markt.
- Launch of Phylox®, a natural anticoccidial solution for poultry, in the Philippines
- Phylox aligns with growing demand for no-antibiotic-ever (NAE) production systems
- Product performance equivalent to common ionophores or chemicals in trials
- Compatible with anticoccidial vaccines
- No withdrawal period required before slaughter
- None.
The launch of Phylox® in the Philippines represents a significant development for the poultry industry. As a natural anticoccidial solution, it addresses the growing demand for antibiotic-free products while tackling a major health challenge. The timing is strategic, considering the high prevalence of coccidiosis during the rainy season in Southeast Asia.
Phylox's ability to be used without a withdrawal period is a key advantage, potentially improving production efficiency and reducing costs associated with conventional treatments. The product's multiple modes of action in disrupting Eimeria life cycles could provide a more robust defense against coccidiosis, potentially reducing resistance issues common with single-mode treatments.
While promising, the true market impact will depend on Phylox's pricing, efficacy compared to established treatments and adoption rate among Filipino poultry producers. Its success could influence industry trends towards more natural solutions in animal health management.
Phylox® presents an intriguing alternative in coccidiosis management. Its claimed equivalence to ionophores and chemicals in performance is noteworthy, but rigorous field testing in Philippine conditions will be crucial. The product's compatibility with anticoccidial vaccines is a significant advantage, potentially allowing for more flexible and comprehensive control programs.
The multiple modes of action mentioned could be a game-changer if they effectively disrupt different stages of the Eimeria life cycle. This approach might mitigate resistance development, a persistent issue with single-mode anticoccidials. However, the specific mechanisms and their long-term effectiveness need thorough evaluation.
From a parasitological perspective, the absence of a withdrawal period is impressive, suggesting minimal residual effects. This feature, combined with its natural composition, aligns well with the growing consumer preference for "cleaner" poultry products.
The introduction of Phylox® could have substantial economic implications for the Philippine poultry industry. Coccidiosis-related losses in feed efficiency, weight gain and mortality rates significantly impact profitability. If Phylox can effectively mitigate these issues, it could lead to improved production economics.
The product's alignment with no-antibiotic-ever (NAE) production systems is particularly relevant given the global shift towards antibiotic reduction in livestock. This could potentially open new market opportunities for Philippine poultry producers, especially in export markets with strict antibiotic regulations.
However, the cost-effectiveness of Phylox compared to traditional treatments will be important for widespread adoption. Producers will need to weigh the potential benefits against implementation costs. If Phylox can demonstrate superior long-term economic outcomes, it could drive a significant shift in industry practices, potentially reshaping the competitive landscape of the Philippine poultry sector.
CHICAGO, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Amlan® International, the animal health business of Oil-Dri® Corporation of America (NYSE: ODC) and a global leader in mineral-based feed additives that optimize the intestinal health of poultry and livestock, announces the launch of Phylox® to the Philippine poultry market. Nezus Philippines Corporation has recently been granted registration to distribute the non-pharmaceutical anticoccidial solution. Phylox is a revolutionary feed additive tailored to prevent coccidiosis in poultry.
Coccidiosis poses a major challenge for the Southeast Asian poultry industry, particularly in the Philippines, where it threatens animal health and the economic stability of poultry production. During the rainy season, environmental conditions favor parasite growth, leading to high prevalence rates in broiler farms. This results in significant economic losses annually due to reduced feed efficiency, weight gain, increased mortality rates, and costly conventional treatment and prevention methods.
Traditionally, the poultry industry has relied on chemical drugs and antibiotics to manage coccidiosis. However, growing consumer and industry preferences for natural, sustainable alternatives have propelled the development of Phylox by Amlan. This innovative product offers poultry producers a safe and effective solution aligned with the principles of no-antibiotic-ever (NAE) production systems.
"We are thrilled to introduce Phylox to the Philippine market," said Dr. Michael Hua, Director, Asia Pacific at Amlan International. "This product launch underscores our commitment to advancing animal health and productivity through natural solutions. Producers are seeking alternative anticoccidials like Phylox, which can be used up to slaughter without a withdrawal period, to reduce resistance and address late-stage coccidial challenges. Phylox not only addresses the critical need for effective coccidiosis control, but meets the evolving market demands for antibiotic-free poultry products."
Amlan will present Phylox at ILDEX 2024, the International Livestock, Dairy, Meat Processing, and Aquaculture Exposition, scheduled from August 28-30, 2024. Visitors are invited to explore this new product at Booths H08 and J07. Product experts will be available to provide in-depth insights into Phylox and its potential impact on enhancing poultry health and profitability.
"We are excited to introduce Phylox at ILDEX," said Jayson Fernandez, Sales Manager, Philippines at Amlan® International. "In trials, Phylox has proven equivalent performance to commonly used ionophores or chemicals and compatibility with anticoccidial vaccines. Its multiple modes of action in disrupting Eimeria life cycles are truly unique. We are confident this product will significantly benefit the Asia Pacific poultry market."
To learn more about Phylox and its modes of action, visit amlan.com/product/phylox.
About Amlan® International
Amlan International is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements. For more information on Amlan International, please visit www.amlan.com.
Contact:
Reagan Culbertson, Vice President of Strategic Marketing, B2B Email: Reagan.culbertson@amlan.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d0f1b3f3-4924-4290-9556-aa61b11507c6
FAQ
What is Phylox® and how does it benefit the poultry industry?
When and where will Amlan International (ODC) showcase Phylox® at ILDEX 2024?
How does Phylox® compare to traditional coccidiosis treatments for poultry?
Who will distribute Phylox® in the Philippines for Amlan International (ODC)?
